Vinblastine, sold under the brand name Velban among others, is a chemotherapy medication, typically used with other medications, to treat a number of types of cancer. This includes Hodgkin's lymphoma, non-small-cell lung cancer, bladder cancer, brain cancer, melanoma, and testicular cancer. It is given by injection into a vein.
Most people experience some side effects. Commonly it causes a change in sensation, constipation, weakness, loss of appetite, and headaches. Severe side effects include low blood cell counts and shortness of breath. It should not be given to people who have a current bacterial infection. Use during pregnancy will likely harm the baby. Vinblastine works by blocking cell division.
Vinblastine was isolated in 1958. An example of a natural herbal remedy that has since been developed into a conventional medicine, vinblastine was originally obtained from the Madagascar periwinkle. It is on the World Health Organization's List of Essential Medicines. |
Read full article at Wikipedia
|
InChI=1S/C19H28O5S/c1- 18- 9- 7- 13(24- 25(21,22) 23) 11- 12(18) 3- 4- 14- 15- 5- 6- 17(20) 19(15,2) 10- 8- 16(14) 18/h3,13- 16H,4- 11H2,1- 2H3,(H,21,22,23) /t13- ,14- ,15- ,16- ,18- ,19- /m0/s1 |
CZWCKYRVOZZJNM-USOAJAOKSA-N |
C1[C@@]2([C@@]([C@@]3(C(C[C@@H](OS(O)(=O)=O)CC3)=C1)C)(CC[C@]4([C@]2(CCC4=O)[H])C)[H])[H] |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
EC 2.7.1.33 (pantothenate kinase) inhibitor
An EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor that interferes with the action of pantothenate kinase (EC 2.7.1.33).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
|
|
View more via ChEBI Ontology
17-oxoandrost-5-en-3β-yl hydrogen sulfate
|
(3-beta)-3-(Sulfooxy)androst-5-en-17-one
|
ChemIDplus
|
17-Ketoandrost-5-en-3beta-yl sulfate
|
ChemIDplus
|
17-oxoandrost-5-en-3β-yl hydrogen sulphate
|
ChEBI
|
3-O-Sulfodehydroepiandrosterone
|
ChemIDplus
|
3beta-Hydroxyandrost-5-en-17-one 3-sulfate
|
KEGG COMPOUND
|
3beta-hydroxyandrost-5-en-17-one 3-sulfate
|
ChEBI
|
3beta-Hydroxyandrost-5-en-17-one 3-sulfate
|
KEGG COMPOUND
|
Androst-5-en-17-on-3beta-yl sulfuric acid
|
ChemIDplus
|
Dehydroepiandrosterone 3-sulfate
|
ChemIDplus
|
Dehydroepiandrosterone monosulfate
|
ChemIDplus
|
Dehydroepiandrosterone sulfate
|
KEGG COMPOUND
|
Dehydroepiandrosterone sulphate
|
ChemIDplus
|
Dehydroisoandrosterone sulfate
|
ChemIDplus
|
Dehydroisoandrosterone-3-sulfate
|
ChemIDplus
|
DHEA sulfate
|
ChemIDplus
|
DHEA sulfate
|
KEGG COMPOUND
|
DHEA-S
|
ChEBI
|
DHEAS
|
ChemIDplus
|
Prasterone sulfate
|
ChemIDplus
|
2227078
|
Reaxys Registry Number
|
Reaxys
|
651-48-9
|
CAS Registry Number
|
ChemIDplus
|
15374110
|
PubMed citation
|
Europe PMC
|
18307294
|
PubMed citation
|
Europe PMC
|
20797618
|
PubMed citation
|
Europe PMC
|
22770225
|
PubMed citation
|
Europe PMC
|
9661815
|
PubMed citation
|
Europe PMC
|
|